Oklahoma 2022 2022 Regular Session

Oklahoma Senate Bill SB1219 Introduced / Bill

Filed 01/07/2022

                     
 
 
Req. No. 2770 	Page 1  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
STATE OF OKLAHOMA 
 
2nd Session of the 58th Legislature (2022) 
 
SENATE BILL 1219 	By: Bullard 
 
 
 
 
 
AS INTRODUCED 
 
An Act relating to medical marijuana; amending 63 
O.S. 2021, Section 427.18 , which relates to packaging 
and labeling requirements ; modifying requirements for 
edible medical marijuana products; and providing an 
effective date. 
 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 
SECTION 1.     AMENDATORY     63 O.S. 2021, Section 427.18, is 
amended to read as follows: 
Section 427.18. A.  An Oklahoma medical marijuana business 
shall not sell, transfe r, or otherwise distribute medical marijuana 
or medical marijuana product that has not been packaged and labeled 
in accordance with this sec tion and rules promulg ated by the State 
Commissioner of Health. 
B.  A medical marijuana dispensa ry shall return medic al 
marijuana and medical marijuana product that does not meet packaging 
or labeling requirements in this sectio n or rules promulgated 
pursuant thereto to the ent ity who transferred it to the dispensary .  
The medical marijuana dispensar y shall document to w hom the item was   
 
 
Req. No. 2770 	Page 2  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
returned, what was returned and the date of the return or dispose of 
any usable marijuana that does not meet these require ments in 
accordance with the Oklahoma Medical Marijuana and Patient 
Protection Act. 
C.  1.  Medical marijuana packagi ng shall be packaged to 
minimize its appeal to children and shall not depict images other 
than the business nam e logo of the medical mariju ana producer and 
image of the product. 
2.  A medical marijuana business shall not place any co ntent on 
a container in a manner that reasonably appears to target 
individuals under the age of twenty -one (21) including, but not 
limited to, cartoon characters or similar images. 
3.  Labels on a container shall not include any false or 
misleading statements. 
4.  No container shall be intentionally or knowingly labeled so 
as to cause a reasonable patient confusion as to whether the medi cal 
marijuana, medical marij uana concentrate, or medical marijuana 
product is a trademarked product or labeled in a manne r that 
violates any federal trademark law or regulation. 
5.  The label on the container shall not make any claims 
regarding health or p hysical benefits to the patie nt. 
6. a. All medical marijuana, medical marijuana concentrate 
and medical marijuana product s shall be in a child-
resistant container at the point of transfer to the   
 
 
Req. No. 2770 	Page 3  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
   1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
patient or caregiver . For all edible medical 
marijuana products, the child-resistant container 
shall be clear. 
b. Edible medical marijuana products in solid or 
semisolid form shall be in the shape of a marijuana 
leaf.  This subparagraph shall not apply to edible 
medical marijuana product s in liquid form. 
D.  The State Department of Health shall develop minimum 
standards for packaging and labeling of medical marijuana and 
medical marijuana products .  Such standards shall include, but not 
be limited to, the required contents of labels to be affixed to all 
medical marijuana and medical marijuana products prior to tran sfer 
to a licensed patient or caregiver, which shall in clude, at a 
minimum: 
1.  THC and other cannabinoid potency, and te rpenoid potency; 
2. A statement indicating that the product has been tested for 
contaminants; 
3. One or more product warnings to be d etermined by the 
Department; and 
4. Any other information the Department deems necessary. 
SECTION 2.  This act shall become effective November 1, 2022. 
 
58-2-2770 DC 1/7/2022 11:01:36 AM